This free article provides a good summary of further disease targets for a brain penetrant PI3K/mTOR inhibitor like paxalisib (see last point of tinhat‘s post above):
https://dx.doi.org/10.3390%2Fijms20225792
Ann: Kazia releases final data from P2 paxalisib trial, page-56
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)